Newsroom

  • Category

  • Press Release

    21 December 24

    CuraTeQ Biologics receives UK MHRA approval for Bevqolva™ (Bevacizumab biosimilar)

    Read more
  • Press Release

    17 January 24

    CuraTeQ Biologics’ Trastuzumab Biosimilar receives recommendation for marketing authorization in India

    Read more